Literature DB >> 1950169

Carbohydrate-induced conformational changes strongly modulate the antigenicity of coronavirus TGEV glycoproteins S and M.

B Delmas1, H Laude.   

Abstract

The carbohydrate composition and the immunoreactivity of the S and M glycoproteins of the coronavirus TGEV were studied at different stages of their maturation. The biosynthesis of S and M was analyzed in the presence of tunicamycin and monensin. The effect of treatment with endoglycosidases H and F and glycopeptidase F on the precursors and mature forms of S and M were also examined. Species 175K and 29K were characterized as high mannose forms of S and M, respectively, and species 220K and 30-36K as complex type glycosylated forms of these two proteins. M was present mainly as a 29K species in mature virions whereas the 175K form of S was not detected, thus implying that the two proteins undergo Golgi modifications at a far different efficiency. Anti-S and -M monoclonal antibodies were examined for their reactivity towards polypeptide species either treated with endo H or produced in the presence of tunicamycin. It was found that (i) among the four major antigenic sites previously defined (Delmas et al., 1986), only site C (amino acids 363 to 371) was notably expressed by the unglycosylated S polypeptide 155K, whereas the three other sites were dependent upon core-glycosylation, (ii) three of the four anti-M mAbs tested did not recognize the unglycosylated M polypeptide 26K. These data led us to conclude that co-translational, but not terminal glycosylation is an essential requirement for both acquisition and maintenance of the antigenicity of TGEV glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1950169      PMCID: PMC7134005          DOI: 10.1016/0168-1702(91)90103-3

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  29 in total

1.  Analysis and simulation of a neutralizing epitope of transmissible gastroenteritis virus.

Authors:  W P Posthumus; J A Lenstra; W M Schaaper; A P van Nieuwstadt; L Enjuanes; R H Meloen
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

2.  Sequence and N-terminal processing of the transmembrane protein E1 of the coronavirus transmissible gastroenteritis virus.

Authors:  H Laude; D Rasschaert; J C Huet
Journal:  J Gen Virol       Date:  1987-06       Impact factor: 3.891

3.  Antigenic structure of transmissible gastroenteritis virus. II. Domains in the peplomer glycoprotein.

Authors:  B Delmas; J Gelfi; H Laude
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

Review 4.  Enzymatic approaches for studying the structure, synthesis, and processing of glycoproteins.

Authors:  A L Tarentino; R B Trimble; T H Plummer
Journal:  Methods Cell Biol       Date:  1989       Impact factor: 1.441

5.  Structural analysis of Rauscher virus Gp70 using monoclonal antibodies: sites of antigenicity and P15(E) linkage.

Authors:  H L Niman; J H Elder
Journal:  Virology       Date:  1982-11       Impact factor: 3.616

6.  Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effect of tunicamycin.

Authors:  P J Rottier; M C Horzinek; B A van der Zeijst
Journal:  J Virol       Date:  1981-11       Impact factor: 5.103

7.  Identification of two epitopes in the carboxyterminal 15 amino acids of the E1 glycoprotein of mouse hepatitis virus A59 by using hybrid proteins.

Authors:  S A Tooze; K K Stanley
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

8.  Antigenicity of the peplomer protein of infectious bronchitis virus.

Authors:  J A Lenstra; J G Kusters; G Koch; B A van der Zeijst
Journal:  Mol Immunol       Date:  1989-01       Impact factor: 4.407

9.  Site of addition of N-acetyl-galactosamine to the E1 glycoprotein of mouse hepatitis virus-A59.

Authors:  S A Tooze; J Tooze; G Warren
Journal:  J Cell Biol       Date:  1988-05       Impact factor: 10.539

10.  Post-translational glycosylation of coronavirus glycoprotein E1: inhibition by monensin.

Authors:  H Niemann; B Boschek; D Evans; M Rosing; T Tamura; H D Klenk
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  9 in total

1.  Processing and antigenicity of entire and anchor-free spike glycoprotein S of coronavirus TGEV expressed by recombinant baculovirus.

Authors:  M Godet; D Rasschaert; H Laude
Journal:  Virology       Date:  1991-12       Impact factor: 3.616

2.  Immunogenicity of the S protein of transmissible gastroenteritis virus expressed in baculovirus.

Authors:  T Tuboly; E Nagy; J R Dennis; J B Derbyshire
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

3.  Single amino acid changes in the viral glycoprotein M affect induction of alpha interferon by the coronavirus transmissible gastroenteritis virus.

Authors:  H Laude; J Gelfi; L Lavenant; B Charley
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

4.  Coronavirus pseudoparticles formed with recombinant M and E proteins induce alpha interferon synthesis by leukocytes.

Authors:  P Baudoux; C Carrat; L Besnardeau; B Charley; H Laude
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

5.  Major receptor-binding and neutralization determinants are located within the same domain of the transmissible gastroenteritis virus (coronavirus) spike protein.

Authors:  M Godet; J Grosclaude; B Delmas; H Laude
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 6.  The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy.

Authors:  Silvia Santopolo; Anna Riccio; M Gabriella Santoro
Journal:  Biochem Biophys Res Commun       Date:  2020-11-28       Impact factor: 3.575

7.  Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence.

Authors:  Anna Riccio; Silvia Santopolo; Antonio Rossi; Sara Piacentini; Jean-Francois Rossignol; M Gabriella Santoro
Journal:  Cell Mol Life Sci       Date:  2022-04-07       Impact factor: 9.207

8.  TGEV corona virus ORF4 encodes a membrane protein that is incorporated into virions.

Authors:  M Godet; R L'Haridon; J F Vautherot; H Laude
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

Review 9.  A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination.

Authors:  C W Olsen
Journal:  Vet Microbiol       Date:  1993-07       Impact factor: 3.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.